Search the Newsreel

Immuron (ASX:IMC): Can Travelan Sales Growth Support Its Strategic Reset?

Immunovant, Inc. (NASDAQ:IMVT) Given Average Rating of "Moderate Buy" by Analysts

Immunovant, Inc. (NASDAQ:IMVT) has received an average recommendation of "Moderate Buy" from ten analysts, with an average twelve-month price target of $44.00. Recent analyst reports show several price target increases and "buy" ratings. Insider transactions indicate recent sales by the COO and CTO, while …

Renaissance Technologies LLC Buys 76,921 Shares of Lyell Immunopharma, Inc. $LYEL

IMCR Q2 Revenues Climb 18.3% as Kimmtrak Demand Helps Offset EPS Miss

Immunocore Holdings plc (IMCR) reported second-quarter 2026 revenues of $115.9 million, exceeding estimates, driven primarily by strong demand for its drug Kimmtrak. Despite the revenue growth, the company posted a wider-than-expected loss of 2 cents per share. Immunocore is also increasing its research and …

Altimmune (ALT) Earnings Date and Reports 2026 $ALT

Liquidity Mapping Around (IMVT) Price Events

This article provides a liquidity mapping analysis for Immunovant Inc. (NASDAQ: IMVT), highlighting a near-term strong sentiment transitioning to mid-term neutrality and long-term positive bias. It details three AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. The …

Technical Reactions to IMCR Trends in Macro Strategies

This article analyzes Immunocore Holdings Plc (NASDAQ: IMCR) using AI models to suggest trading strategies. It highlights a strong near-term sentiment potentially challenging persistent mid and long-term weakness, identifying an exceptional short setup. The report provides specific entry, target, and stop-loss levels for position, …

H.C. Wainwright raises Immix Biopharma price target to $25 By Investing.com

H.C. Wainwright has increased its price target for Immix Biopharma (NASDAQ:IMMX) to $25 from $20, reiterating a Buy rating, despite the company posting a wider net loss for Q2 2026 than previously estimated. The firm cited Immix's strong cash position of $234.2 million, providing …

TAG Immobilien: Mieteinnahmen steigen 6,7%, Prognose erhöht

Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day

Zimmer Biomet Holdings Inc. (ZBH) saw its stock advance by 1.27% to $97.78 on Monday, outperforming the broader market which experienced a dismal trading session. This rise broke a two-day losing streak for the company's shares. The S&P 500 Index and Dow Jones Industrial …

Shimmick Q2 Results: Gross margin rises 53% QoQ, backlog hits $991M

Shimmick Corporation reported strong Q2 2026 results with a 53% QoQ rise in gross margin to $12 million, achieving positive Adjusted EBITDA for the fourth consecutive quarter. Despite a revenue decline to $107 million due to winding down legacy projects, the company's backlog reached …

SHIM Stock Price and Chart — NASDAQ:SHIM

This article provides a detailed overview of Shimmick Corporation (NASDAQ: SHIM) stock, including its current price, key financial metrics, recent earnings report highlights, and analyst ratings. It also features frequently asked questions about the company's stock performance, market capitalization, revenue, and dividend policy.

H.C. Wainwright raises Immix Biopharma price target to $25

H.C. Wainwright has raised its price target for Immix Biopharma (NASDAQ:IMMX) to $25 from $20, while reiterating a Buy rating, citing an advanced discounted cash flow valuation and consideration of ex-U.S. sales from NXC-201. The firm updated its earnings estimates, now projecting a net …

Immunic (IMUX) director Elena Ridloff receives 50,740 stock options at $14.54

Immunic (IMUX) director Elena Ridloff was granted 50,740 stock options on August 6, 2026, with an exercise price of $14.54 per share. These options, which vest monthly over three years and expire on August 6, 2036, significantly increase her direct holdings. The transaction was …

Shimmick forecasts $525M-$575M 2026 revenue while building mission-critical unit

Earnings Call Insights: Shimmick Corporation (SHIM) Q2 2026 MANAGEMENT VIEW * “During the second quarter, we continued to execute on our strategy by making further progress winding down noncore projects while driving operational improvements across the business that enhance efficiency, improve execution and support …

Shimmick Corp (SHIM) (Q2 2026) Earnings Call Highlights: Backlog Surges to Two-Year High as ...

Shimmick Corp (SHIM) reported its Q2 2026 earnings, showcasing a significant improvement in gross margin and adjusted EBITDA, with net loss narrowing. The company's backlog reached a two-year high of $991 million, indicating strong future revenue visibility despite a slight decline in consolidated revenue …

Shimmick Corporation (SHIM) Reports Q2 Loss, Misses Revenue Estimates

Immunic appoints Elena Ridloff to board of directors By Investing.com

Immunic, Inc. has appointed Elena Ridloff to its board of directors, effective Wednesday. Ridloff brings over 20 years of experience in finance, corporate development, and capital markets within the biopharmaceutical industry. Immunic is a late-stage biotechnology company developing oral therapies for neurologic diseases and …

Immunome (NASDAQ:IMNM) Director Isaac Barchas Sells 15,248 Shares

Immunome (NASDAQ:IMNM) Director Isaac Barchas sold 15,248 shares of the company's stock on August 7th for over $397,000, reducing his direct holdings by 17.39%. This sale was part of a pre-arranged Rule 10b5-1 plan, and he has sold more than 320,000 shares since late …

Shimmick (NASDAQ: SHIM) cuts losses as margins rise despite revenue drop

Archer Aviation (NYSE: ACHR) Among IBRX, JOBY, SCKT Leading Technology Stocks – Plus More in Focus

This article highlights several technology and growth companies, including Archer Aviation (ACHR), ImmunityBio (IBRX), Sphere 3D Corp. (ANY), Graphene Manufacturing Group (GMG), and Socket Mobile (SCKT), which are attracting investor attention due to recent corporate, technology, and strategic developments. Archer Aviation is expanding its …

BitMine Immersion Technologies, Inc. price history | XBMNR historical price data

This article provides the historical price data for BitMine Immersion Technologies, Inc. (XBMNR), allowing users to track its performance over time. It includes daily open, high, close, low prices, and trading volume. The content also features a FAQ section addressing the all-time highest price …

Shimmick's Backlog Reaches About $991M, Highest Since Q1 2024

Shimmick Corporation (NASDAQ: SHIM) announced its Q2 2026 results, reporting a backlog of approximately $991 million, the highest since Q1 2024. The company's net loss narrowed to $5 million, and Adjusted EBITDA reached $4 million, marking its fourth consecutive positive quarter. Shimmick also reaffirmed …

Hennion & Walsh Asset Management Inc. Has $4.65 Million Stock Holdings in Immunovant, Inc. $IMVT

Hennion & Walsh Asset Management Inc. significantly increased its stake in Immunovant, Inc. (NASDAQ:IMVT) by 32.6% in the second quarter, now holding 120,686 shares valued at $4.65 million. Despite this institutional confidence and a "Moderate Buy" consensus rating from analysts, Immunovant reported a wider-than-expected …

BMNR Stock Trades Sideways As Financials Signal High-Risk Setup

BitMine Immersion Technologies Inc. (BMNR) stock is trading sideways after a steady uptrend, signaling slowing momentum despite a strong balance sheet with $340M in cash and minimal debt. The company exhibits a high-burn, early-stage profile with deeply negative margins and returns, presenting a high-risk, …

IMCR Jumps 21.2% in 3 Months as Kimmtrak Growth Fuels More Momentum

Immunocore Holdings plc IMCR has gained 21.2% over the past 12 weeks, putting the durability of that advance in focus. Kimmtrak demand and late-stage pipeline progress give investors concrete operating and clinical milestones to watch. The stock's shorter-term gains have been more modest, while …

Is IMCR Worth Buying as Kimmtrak Growth Meets a Premium Valuation?

Immunocore Holdings (IMCR) presents a trade-off between its growing Kimmtrak product revenue and a premium valuation. While Kimmtrak's sales are strong and late-stage studies could expand its market, the company's reliance on a single product and higher-than-average valuation metrics pose risks. Analysts currently recommend …

FTSE 100 slips as real estate stocks react to results; Persimmon gains while Tritax falls

Shimmick Corporation Announces Second Quarter 2026 Results

Shimmick Corporation (NASDAQ: SHIM) announced its Q2 2026 financial results, reporting $107 million in revenue and a 53% quarter-over-quarter increase in gross margin. The company achieved its fourth consecutive quarter of positive Adjusted EBITDA at $4 million and reported a record backlog of $991 …

Bitmine Buys Another 7,391 Ethereum And Increases Staked Position

Bitmine Immersion Technologies (BMNR) has acquired an additional 7,391 Ethereum, bringing its total holdings to 4.8% of Ethereum's circulating supply, nearing its 5% target. The company has also increased its staked ETH to 87% of its holdings, representing 5,067,309 ETH valued at $9.8 billion, …

LEG IMMOBILIEN AKTIE: AI-Analysen, Prognose & Kursziel

Bitmine Buys 7,391 ETH for $14.3 Million, BMNR Down 2%: What's Going On?

Bitmine Immersion (NYSE: BMNR) recently purchased 7,391 Ethereum (ETH) for $14.3 million, continuing its 14-month streak of weekly ETH acquisitions. The company now holds 5,805,238 ETH, representing 4.8% of Ethereum's total circulating supply. Chairman Tom Lee attributes the continued crypto investment to easing financial …

Tom Lee's Bitmine Buys $14M in Ethereum as Cash Falls to $104M

Ethereum treasury company Bitmine Immersion Technologies said Monday it bought 7,391 ETH over the past week, worth about $14 million, taking its holdings to 5,805,238 ETH as of Friday evening. The company bought 10,399 ETH the week before. Total crypto, cash and what the …

ImmunityBio appoints Jim Yong Kim as vice chairman

ImmunityBio, Inc. (NASDAQ:IBRX) has announced the appointment of Dr. Jim Yong Kim as vice chairman, who will focus on international partnerships and global access initiatives within the newly created Office of the Executive Chairman. Dr. Kim, a former president of the World Bank Group …

Scinai Names Eran Kuratz to Lead CDMO Supply Chain and Business Processes

Scinai Immunotherapeutics Ltd. has appointed Eran Kuratz as the head of supply chain and business process administration for its Scinai Biopharma Services subsidiary. This strategic move aims to strengthen operational leadership and integrate the company's expanded contract development and manufacturing organization (CDMO) across its …

Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.81 Million Tokens, and Total Crypto and Total Cash Holdings of $11.6 Billion

Bitmine Immersion Technologies (BMNR) announced that its Ethereum (ETH) holdings have reached 5.81 million tokens, contributing to total crypto and cash holdings of $11.6 billion. The company also stated it has repurchased over 19 million shares since July 2026 and that its MAVAN platform …